H. Nishimura

Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2)

I. Shimomura, K. Fukui, J. Terasaki, 2021, Advances in Therapy.

An increased dose of insulin detemir improves glycaemic control and reduces body weight of Japanese patients with diabetes

H. Fujii, Y. Watanabe, T. Miyakawa, 2010, International journal of clinical practice.

Protamine-containing insulin but not analog insulin and duration of insulin use are risk factors for the production of insulin autoantibodies in insulin-treated patients with diabetes mellitus.

J. Takeda, K. Iizuka, H. Nishimura, 2014, Endocrine journal.

The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective

R. Pollock, W. J. Valentine, T. Pilgaard, 2011, Journal of medical economics.